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Abstract
© 2020 Elsevier Ltd A phytochemical study on the root extracts of Neorautanenia mitis, a Nigerian
medicinal plant used in the management of diarrhea, led to the isolation of one new and 19 known natural
products. These compounds and crude extracts were evaluated for Cystic Fibrosis Transmembrane
Conductance Regulator (CFTR) Cl− channel and calcium-activated Cl− channel (TMEM16A) inhibitory
activities in T84 and Calu-3 cells, respectively. Four compounds namely dolineon, neodulin, pachyrrhizine,
and neotenone inhibited cAMP-induced Cl− secretion across T84 cell monolayers with IC50 values of
~0.81 μM, ~2.42 μM, ~2.87 μM, and ~4.66 μM, respectively. Dolineon having the highest inhibitory
activity also inhibited a Ca + activated Cl− channel (TMEM16A) with an IC50 value of ~4.38 μM. The in
vitro antidiarrheal activity of dolineon was evaluated on cholera toxin (CT) induced chloride secretion in
T84 cells, where it inhibited CT-induced chloride secretion by >70% at 100 μM. Dolineon also inhibited CTinduced fluid secretion by ~70% in an in vivo mouse closed loop model at a dose of 16.9 μg/loop. The
cytotoxicity of the extracts and compounds was evaluated on KB, Vero and BHK21 cells, dolineon showed
low cytotoxicity of >29.6 μM and 57.30 + 6.77 μM against Vero and BHK21 cells, respectively. Our study
revealed that several compounds isolated from N. mitis showed antidiarrheal activity. The most active
compound dolineon can potentially serve as a lead compound towards the development of CFTR and
TMEM16A inhibitors as future therapeutics for secretory diarrhea.
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ABSTRACT
A phytochemical study on the root extracts of Neorautanenia mitis, a Nigerian medicinal plant
used in the management of diarrhea, led to the isolation of one new and 19 known natural
products. These compounds and crude extracts were evaluated for Cystic Fibrosis
Transmembrane Conductance Regulator (CFTR) Cl- channel and calcium-activated Cl- channel
(TMEM16A) inhibitory activities in T84 and Calu-3 cells, respectively. Four compounds namely
dolineon, neodulin, pachyrrhizine, and neotenone inhibited cAMP-induced Cl− secretion across
T84 cell monolayers with IC50 values of ~0.81 µM, ~2.42 µM, ~2.87 µM, and ~4.66 µM,
respectively. Dolineon having the highest inhibitory activity also inhibited a Ca+ activated Clchannel (TMEM16A) with an IC50 value of ~4.38 µM. The in vitro antidiarrheal activity of
dolineon was evaluated on cholera toxin (CT) induced chloride secretion in T84 cells, where it
inhibited CT-induced chloride secretion by >70% at 100 µM. Dolineon also inhibited CTinduced fluid secretion by ~70% in an in vivo mouse closed loop model at a dose of 16.9
µg/loop. The cytotoxicity of the extracts and compounds was evaluated on KB, Vero and
BHK21cells, dolineon showed low cytotoxicity of > 29.6 µM and 57.30 + 6.77 µM against Vero
and BHK21 cells, respectively. Our study revealed that several compounds isolated from N. mitis
showed antidiarrheal activity. The most active compound dolineon can potentially serve as a lead
compound towards the development of CFTR and TMEM16A inhibitors as future therapeutics
for secretory diarrhea.
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1. Introduction
Herbal preparations made by water maceration of the rhizome (root) of Neorautanenia mitis
(A. Rich) Verdc. (Fabacae) are used by Traditional Medicine (TM) practitioners and livestock
owners in Nigeria, as an effective means of treating the symptoms of diarrhea in both humans
and livestock (Dawurung et al., 2019). This plant is native to West, Central and South African
countries, and in Nigeria it is found in the middle belt region (Dawurung et al., 2019; Vongtau et
al., 2004). Some species of Neorautanenia have been studied for their medicinal properties
including N. mitis, formally named Neorautanenia pseudopacyrrhiza (Crombie and Whiting,
1962; Crombie and Whiting, 1963), N. amboensis (Breytenbach and Rall, 1980), N. edulis (Brink
et al 1974; Rall et al 1970; Van Duuren, 1961) and the closely related Pachyrrhiza erosus
(Krishnamurti et al., 1970). N. mitis is used in TM practice in many African countries to treat
conditions such as; syphilis, dysmenorrhea, scabies, rashes, female frigidity, and diarrhea.
(Dawurung et al., 2019; Van Duuren, 1961; Vongtau et al., 2000). Phytochemical and biological
studies on this plant have been reported by many groups. Individual phytochemicals and crude
extracts have been shown to have cytotoxicity (Sakurai et al., 2006), acaricidal, insecticidal
(Puyvelde, et al., 1987), larvicidal, mosquitocidal (Joseph et al., 2004), antinocicetive, antiinflammatory (Vongtau et al., 2000; 2004), antimicrobial (Lasisi and Adesomoju, 2015) and
antidiarrheal activities (Dawurung et al., 2019). In our current study, we continue to explore
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Nigerian medicinal plants that are useful in alleviating the symptoms of diarrhrea and sought to
identify the compound(s) responsible for this activity.

Diarrhea is a global problem and a common symptom in many diseases, when it persists; it can
lead to loss of electrolytes, dehydration and in severe cases it can be fatal (Levine, et al., 2017;
Mandal and Sahi, 2017). Causes can range from bacterial, viral, fungal and parasitic infections,
the side effects from drugs and other physiological disorders. In developing countries, periodic
outbreaks of severe secretory diarrhea caused by Vibrio cholerae results in high morbidity and
mortality, especially in children under the age of 5 years. Despite improvements in diarrhea case
management, it still accounts for 1.5 million deaths annually and 1% of deaths in children under
the age of 5 years (Mandal and Sahi, 2017). Most of these deaths are recorded in developing
countries, with 78% child deaths from diarrhea occurring in the African and South-East Asian
regions (World Gastroenterology Global Guidelines, 2012). While in Nigeria, the mortality rate
in children was about 331.3 per 100,000 in 2016 (GBD 2016 Diarrhoeal Disease Collaborators,
2018). Diarrhea, however, remains a common reason for hospital consultation in developed
countries leading to discomfort and loss of productivity (Fine and Schiller, 1999). The search for
new drugs and approaches in the management of diarrhea are eminent and medicinal plants have
been reported as effective means of treating the symptoms of diarrhea among farmers, rural
dwellers and TM practitioners (Dawurung et al., 2019; Offiah et al.; 2011; 2012). The World
Health Organisation (WHO) also suggested the use of herbal formulations in treating these
conditions (WHO, 1993).

One approach in the treatment of secretory diarrhea involves the use of CFTR and TMEM16A
inhibitors. CFTR is a cAMP-activated chloride channel expressed in epithelia of the intestine and

5

other organs and tissues, where it facilitates transepithelial fluid transport. In the intestine,
cholera toxin (CT) released by Vibrio cholera leads to a rise in intracellular cAMP which
triggers CFTR chloride secretion and is followed by massive fluid secretion into the GIT
resulting in diarrhea. CFTR and TMEM16A inhibitors are specific and effective in the
management of secretory diarrheas (Muangnil et al., 2018; Tradtrantip et al., 2010). Herein we
demonstrate the CFTR and TMEM16A inhibitory activities and cytotoxicity of the compounds
isolated from N. mitis. (Fig. 1).

2. Results and discussion
The phytochemical components of the dichloromethane (DCM) extract of the dried roots of
N. mitis were separated by thin layer chromatography (TLC), column chromatography (CC) over
silica gel or Sephadex LH-20, and preparative thin layer chromatography (PTLC), to give the
following compounds; neoduleen (1) (Brink et al., 1974), neodulin (2) (Puyvelde et al., 1987),
ferulic acid (3) (Fraga et al., 2017), ambonane (4) (Breytenbach and Rall, 1980), stigmasterole
(5) (Chaturvedula and Prakash, 2012; Van Duuren, 1961), pachyrrhizine (6) (Puyvelde et al.,
1987), neotenone (7) (Puyvelde et al., 1987), 7-methoxy-3-(6-methoxybenzo[d][1,3]dioxol-5-yl)
chroman-4-one (8) (Suguinome, 1959), 12a-hydroxydolineon (9) (Puyvelde et al., 1987),
dolineon

(10)

(Puyvelde

et

al.,

1987),

(-)-2-isopentenyl-3-hydroxy-8-9-

methylenedioxypterocarpan (11) (Rall et al., 1971), nepseudin (12) (Crombie and Whiting,
1963),

neorautenol (13) (Brink et al., 1974; Mitscher et al., 1988), isoneorautenol (14)

(Nkengfack et al., 1995), (-)-2-hydroxypterocarpin (15) (Rall et al., 1970), rotenone (16)
(Oberholzer et al., 1974; Phrutivorapongkul et al., 2002), 12a-hydroxyrotenone (17) (Oberholzer
6

et al., 1974; Puyvelde et al., 1987), dehydroneotenone (18) (Puyvelde et al., 1987), rautandiol A
(19) (Sakurai et al., 2006) and rautandiol B (20) (Sakurai et al., 2006) Fig. 1.
Compound 8 was a new natural product, while single crystal X-ray diffraction allowed the
configurations of compounds 11 and 20 to be established for the first time as (6a-R,11a-R) and
(6a-R,11a-R, 2'-S), respectively (Fig. 2). This study has also allowed us to provide complete
NMR assignments and supporting spectroscopic data for compounds 1, 3, 4, 11, 12, 13 and 15
for the first time. Compound 3 was isolated as a single entity for the first time, therefore its full
physical and spectroscopic data is also provided. Nine compounds, 1, 3, 4, 5, 8, 11, 13, 14 and
15, were isolated from N. mitis for the first time.
Because the TM practitioners administer the aqueous extract of the roots of N. mitis orally to
treat the symptoms of diarrhea, we also prepared the crude aqueous extract using the traditional
method (water maceration) (Dawurung et al., 2019). This extract was concentrated in vacuo and
further extracted with chloroform and the components separated by CC to give compounds 2, 6,
7 and 18 with the percentage yields of 0.20%, 0.58%, 1.1% and 0.78%, respectively based on the
dry weight of the root material.
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Fig. 1. Chemical structures compounds 1-20.
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Fig. 2. Crystal structures of compounds 11 and 20 (CCDC 1973442 and 1972703, respectively).
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Table 1
1
H NMR and 13C NMR spectroscopic data of compound 8 (CDCl3) a
1
13
No
H NMR
C NMR
HMBC
2
4.57 – 4.45 (m, 2H)
71.3
C-8a, 1', 3, 4
3
4.25 (dd, J = 11.3, 5.5, 1H)
47.5
C-1', 2, 2', 4, 6'
4
191.5
5
7.92 (d, J = 8.8, 1H)
129.4
C - 4, 7, 8a
6
6.61 (dd, J = 8.8, 2.0, 1H)
109.9
C - 4a, 8
7
165.8
8
6.44 (d, J = 2.0, 1H)
100.7
C- 6, 7, 8a
4a
115.5
8a
163.8
1'
115.6
2'
152.8
3'
6.56 (s, 1H)
95.3
C - 4', 5'
4'
141.3
5'
147.7
6'
6.59 (s, 1H)
109.7
C - 3, 2', 4', 2''
2''
5.91 (s, 2H)
101.3
C - 4', 5'
OCH32'
3.74 (s, 3H)
56.6
C - 2'
OCH37
3.85 (s, 3H)
56.6
C–7
a

Assignments were made on the basis of COSY, HSQC and HMBC correlations,
chemical shift values are in δ (ppm), and coupling constants (J) are in Hz.
Compound 8 was isolated as a white solid after purification by Prep. TLC, mp 133-135°C, and
[α]22 -11.2 (c 0.2 CHCl3). Its HRESITOFMS data afforded an [M + H] + ion peak at m/z
329.1025, implying a molecular formula of C18H16O6 (calcd for C18H17O6, m/z 329.1025). The
13

C NMR and DEPT spectra indicated the presence of a total of 18 carbons, eight of which were

quaternary, five aromatic methines, two methylenes, one sp3 methine and two methoxy carbons
(Table 1). The resonance for the oxygenated aromatic carbons were at δC 165.8 (C-7), 163.8 (C8a), 152.8 (C-2'), 147.7 (C-5'), 141.3 (C-4'), while C-4 resonated at δC 191.5. The 1H NMR
spectrum showed aromatic proton resonances at δH 7.92 (d, J = 8.8 Hz, 1H), 6.61 (dd, J = 8.8,
2.1 Hz, 1H), 6.59 (s, 1H), 6.56 (s, 1H), and 6.44 (d, J = 2.0 Hz, 1H). The HMBC correlations
(Table 1) allowed the assignment of the aromatic ring protons to the A and B rings which were
consistent with an isoflavonoid skeleton. The methylenedioxy group, δH 5.91 (s, 2H), was
10

substituted at C-4' and C-5' on the B ring from its HMBC correlations, while the 1H NMR
resonances at δH 3.85 (s, 3H) and 3.74 (s, 3H) represented the methoxy groups that were
substituted at C-7 and C-2' on the A and B rings, respectively. The methylene protons at δH 4.57
– 4.45 (m, 2H) and the methine proton at δH 4.25 (dd, J = 11.3, 5.5 Hz, 1H) were part of the
heterocyclic C ring. Their chemical shifts and splitting patterns were comparable to those of the
corresponding protons of compound 7 (Puyvelde et al., 1987), which was also isolated in this
study. Compound 8, or its isomer was prepared by synthesis; however the authors were not able
to distinguish between the two possible structures. The NMR spectroscopic data of the synthetic
compound was not provided to allow for a comparison (Suguinome, 1959).
Compounds 2, 6, 7, 10, 11, 15, 16, and 18-20, which we had in sufficient quantities, and the
crude DCM and aqueous extract were tested in a primary screen at 5 µM (compound) or 5µg/mL
(extracts) for their CFTR inhibitory activities. The results are shown in Table 2.

Table 2
Primary Screening of Compounds and the DCM (ABDCM) and Aqueous (ABAQ) Extracts of N.
mitis for CFTR Inhibitory Activity
Compound (5µM)
/Extract (5µg/mL)
2
6
7
10
11
15
16
18
19
20
ABDCM
ABAQ

% CFTR
Inhibition
~45%
~60%
~60%
~85%
~75%
Inactive
~80%
Inactive
Inactive
Inactive
~70%
~60%
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The IC50 values of the most active compounds and of the two extracts in the inhibition of cAMPinduced chloride secretion were determined as shown in Figure 3 and Figure 4. Compounds 2, 6,
7, and 10 and the aqueous extract (ABAQ) inhibited cAMP-induced chloride secretion in a
concentration-dependent manner with significant IC50 values of 2.23 ± 0.26 µM, 6.21 ± 0.78 µM,
2.86 ± 0.43 µM, 0.81 ± 0.19 µM and 2.49 ± 0.43 µg/mL, respectively, when compared to the
reference compound CFTRinh-172 which showed a consistent IC50 of ~5 µM in intact T84 cells.
These results indicated that compound 10 had the highest inhibitory activity. No further
investigations were carried out on compounds 11 and 16 or the DCM extract (ABDCM), because
they did not give dose-dependent responses.
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A

B

Fig. 3. Inhibitory effects of compounds 2, 6, 7 and 10 on cAMP-induced chloride secretion in
T84 cells. (A) Dose response studies of compounds 2, 6, 7 and 10 on cAMP-induced chloride
secretion. The representative traces of apical ISC on T84 cells are shown. (B) Data were fitted to
the Hill equation and expressed as means of %forskolin-stimulated ISC ± S.E.M. (n=3).
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A

B

Fig. 4. Inhibitory effects of ABAQ on cAMP-induced chloride secretion in T84 cells. (A) Dose
response studies of ABAQ on cAMP-induced chloride secretion. The representative traces of
apical ISC on T84 cells is shown. (B) Data were fitted to the Hill equation and expressed as
means of %forskolin-stimulated ISC ± S.E.M. (n=3).
TMEM16A is a Ca2+-activated Cl- channel that transports Cl across biological membranes. It
plays an important role in various physiological processes, and also an active role in fluid
secretion in epithelial cells. The TMEM16A inhibitory effects of the isolated compounds and the
two extracts were assessed by apical Cl- current (ICl-) analysis in human airway epithelial (Calu3) cells since these cells endogenously expressed high levels of TMEM16A (Jia et al., 2015).

Table 3
Primary Screening of Compounds of N. mitis for TMEM16A Inhibitory Activity in Human
Airway Epithelial (Calu-3) Cells
Compound (10µM)
/Extract (10µg/mL)
2
6
7
10
11
15
16
18
19
20

% TMEM16A
Inhibition
~42%
~1%
~3%
~24%
~28%
<1%
~19%
~4%
~10%
~44%
14

~86%
ABDCM
~76%
ABAQ
As shown in Figure 5, pre-treatment of Calu-3 cells with MONNA, a specific TMEM16A
inhibitor, (Oh et al., 2013) almost completely diminished Cl- current induced by Eact, a specific
TMEM16A activator, (Namkung et al., 2011) ensuring functional existence of TMEM16A in
Calu-3 cells. The TMEM16A inhibitory effects of the isolated compounds and extracts were
determined at 10 µM or 10 µg/mL, respectively. This primary screening revealed that the
ABDCM and ABAQ extracts produced the highest TMEM16A inhibition (Table 3). The
inhibitory activity of the DCM extract was determined as shown in Figure 6. ABDCM inhibited
TMEM16A in a concentration-dependent manner with an IC50 value of 8.05±0.96 µg/mL, with
complete inhibition observed at 20 µg/mL.

Fig. 5. Validation of TMEM16A activation in Calu-3 cells. (A) Representative traces of change
in Cl- current induced by 10 μM Eact with or without 10 μM MONNA pretreatment. (B) Data
were fitted to the Hill equation and expressed as means of Eact-induced Cl- current (mean ±
S.E.M, n=3). ***P<0.001.
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Fig. 6. ABDCM dose-dependently inhibited TMEM16A in Calu-3 cells. (A) Representative trace
of change in Cl- current. ABDCM at indicated concentration were applied 20 min prior to
TMEM16A activation by Eact (10 μM). (B) Dose-response relationship of TMEM16A inhibition
by ABDCM. Data were fitted to the Hill equation and expressed as means of Eact-induced Clcurrent (mean ± S.E.M, n=3).
To help understand the possible mechanism of action of compound 10 on CFTR chloride channel
activity, apical IClˉ current was measured in basolateral permeabilized T84 cells. These
experiments were designed to determine whether compound 10 inhibited the CFTR chloride
channel through cAMP alteration. As shown in Figure 7, compound 10 showed concentrationdependent inhibition of CFTR-mediated apical IClˉ stimulated by various cAMP agonist,
including forskolin (adenylate cyclase activator), forskolin plus IBMX (phosphodiesterase
inhibitor) and CPT-cAMP (a cell-permeable cAMP) with IC50 values of 2.12±0.39 µM, 1.9±0.18
µM and 1.49±0.23 µM, respectively. These findings indicated that CFTR inhibition by
compound 10 does not involve cAMP alteration.
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A

B

Fig. 7. Effect of compound 10 on CFTR-mediated apical IClˉ in T84 cells. (A) The representative
trace of apical IClˉ stimulated by forskolin (20 µM), forskolin plus IBMX (100 µM) and CPTcAMP (100 µM). (B) Data were fitted to the Hill equation and expressed as means of %agoniststimulated IClˉ ± S.E.M. (n=3).
CFTR Cl- current can be suppressed by negative regulators including protein phosphatase (PP)
and multidrug-resistance protein 4 (MRP4). As shown in Figure 8, compound 10 concentrationdependently inhibited CFTR-mediated apical IClˉ after treatment with the protein phosphatase
inhibitor (Na3VO4) or MRP4 inhibitor (MK571) with IC50 values of 1.93±0.04 µM and 2.4±0.08
µM, respectively. Thus CFTR inhibition by compound 10 was not significantly affected by pretreatment with protein phosphatase inhibitor or MRP4 inhibitor. These findings indicate that the
inhibitory effect of compound 10 on CFTR chloride channel activity does not involve activation
of protein phosphatase and/or MRP4.
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A

B

Fig. 8. No involvement of protein phosphatase and MRP4 in the inhibition of CFTR chloride
channel activity by compound 10 (A) Representative trace of apical IClˉ stimulation after
pretreatment with Na3VO4 (protein phosphatase inhibitor; 1 mM) and MK571 (MRP4 inhibitor;
20 µM). (B) Data were fitted to the Hill equation and expressed as means of %forskolinstimulated IClˉ ± S.E.M. (n=3).
Apart from CFTR, intestinal Ca2+-activated Cl- channel (CaCC) also plays a pivotal role in the
pathogenesis of secretory diarrheas.43 Therefore, we investigated whether compound 10 could
inhibit intestinal CaCC. Apical Cl- current measurement was performed in T84 cell monolayers.
The results showed that compound 10 inhibited intestinal CaCC current in a concentrationdependent manner with an IC50 value of 4.38±0.38 µM. Maximal inhibition was observed at 100
µM as shown in Figure 9.
18

A

B

Fig. 9. Effect of compound 10 on intestinal CaCC activity. (A) Representative trace of apical IClˉ.
T84 cell monolayers were permeabilized with amphotericin B at basolateral membrane, and 5
µM of CFTRinh-172 was applied to apical solution 15 min prior to addition of ATP (100 µM).
Compound 10 was then added to both apical and basolateral solution at indicated concentration.
(B) Data were fitted to the Hill equation and expressed as means of ATP-induced IClˉ ± S.E.M.
(n=3).
Next, we evaluated the anti-diarrheal activity of compound 10 in in vitro models of chloride
secretion in T84 cell monolayers and an in vivo closed loop model of fluid secretion induced by
cholera toxin (CT) challenge (Muanprasat and Chatsudthipong, 2013). It was found that
compound 10 inhibited CT-induced chloride secretion in T84 cells with an IC50 value of 1.16
µM and >70% of inhibition of fluid secretion at 100 µM (Figure 10A). In a mouse closed loop
model, the weight/length ratios of loops were determined to assess intestinal fluid secretion. In
this experiment, intestinal loops were instilled with CT (1 µg/loop) with or without compound 10
at a dose of 16.9 µg/loop. Interestingly, compound 10 at this dose inhibited CT-induced fluid
secretion by ~70% (Figure 10B). These results indicate that compound 10 could serve as a lead
compound for the development of future CFTR inhibitors that may have therapeutic potential for
the treatment of diarrhea.
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A

B

Fig. 10. Anti-diarrheal application of compound 10 (A) Effect of compound 10 on CT-induced
chloride secretion in T84 cells. (B) Effect of compound 10 on CT-induced intestinal fluid
secretion in mouse close-loop. Ileal loops were instilled with phosphate-buffered saline (PBS) or
PBS containing cholera toxin (1 µg/loop) with or without intraluminal (i.l.) administration of
compound 10 (16.9 µg/loop). Loop weight/length ratios were evaluated 6 h after CT challenges.
***, P < 0.001 when compared with control ###, P < 0.001 when compared with the CT-treated
group (one-way ANOVA) (n = 5).
Most of the isolated compounds were assayed for cytotoxicity against KB (mouth epidermal
carcinoma cells), Vero (kidney epithelial cells of an African green monkey) and BHK21 (baby
hamster kidney fibroblast) cell lines. Table 4 shows the results of these assays. The aqueous
(ABAQ) and DCM (ABDCM) extracts showed significant activities against KB cells with IC50
values of 1.0±0.2 and 0.35±0.04 µg/mL, respectively, they were also cytotoxic against Vero cells
20

with IC50 values of 5.8±1.1 and 2.7±0.6 µg/mL, respectively. Compound 16 and 17 were
identified as responsible for the cytotoxicity observed in the crude DCM extract, as they also
showed high cytotoxic activities against KB cells with IC50 values of 0.006±0.003, and
0.09±0.003 µM, respectively. This is similar to the activity reported for these compounds against
MCF-7 breast cancer cells and A-549 lung cancer cells (Sakurai et al., 2006). However, these
compounds were found to be highly toxic against Vero cells with IC50 values of 0.17±0.02, and
0.02±0.02 µM, respectively. Compound 17 was the most toxic, consistent with its insecticidal
properties (Puyvelde et al., 1987). Compounds 2, 6, 7, 10 and 20 showed no cytotoxicity.
Importantly, compound 10 being identified as a lead CFTR inhibitor showed low toxicity on
non-cancerous cell lines giving IC50 values of >29.6 and 57.30 µM against Vero and BHK21
cells, respectively. Therefore consistent with earlier reports (Estrella-Parra et al., 2014).
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Table 4
Compounds (µM) /
Crude
Extracts
(µg/mL)
ABAQ Extract
ABDCM Extract
1
2
3
6
7
8
9
10
11
12
15
16
17
18
20
Ellipticine

Cytotoxicity
KB

(IC50)

VERO

BHK21

1.0±0.2
5.8±1.1
SR - 5.8
0.35±0.04
2.7±0.6 5.25±1.28
SR - 7.71
>31.0
>31.0
>32.5
>32.5
41.68±8.56
> 17.2
> 17.2
>32.3
>32.3
7.89±1.05
>31.0
>31.0
>100
>31.0
>31.0
>28.5
>28.5
>29.6
>29.6
57.30±6.77
>28.4
>28.4
>28.2
>28.2
> 31.8
> 31.8
0.065±0.003 0.17±0.02
SR – 2.62
0.09±0.003 0.02±0.02
12.05
>30.9
>30.9
42.87±9.46 89.49±8.4 82.68±7.75
7
0.95±0.34
SR – 133
1.02±0.29

Cytotoxicity
Extracts

of
and

Crude
Isolated

Compounds from N. mitis

3. Conclusions

This study has led to the isolation and characterization of one new compound (8) and 19
known compounds from the root extracts of N. mitis. With the aid of crystallography, the
absolute configurations of two compounds (11 and 20) were determined. The presence of
multiple compounds (2, 6, 7, and 10) with CFTR inhibitory activity in the extracts of N. mitis
may account for its anti-secretory activity and there by its antidiarrheal activity as acclaimed by
TM practitioners. The most potent CFTR inhibitor, compound 10 (IC50 = 0.81 ± 0.19 µM), was
judged to be relatively safe based on the IC50 values of >29.6 µM against Vero cells and
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57.30±6.77 µM against BHK21 cells. Therefore, this compound can be considered as a potential
lead candidate for drug development towards the treatment of secretory diarrhea.
4. Experimental section

4.1.General experimental procedures
The structures of all isolated compounds were elucidated using the following spectroscopic
methods; IR, MS, NMR (1D and 2D), MP, and optical rotation. The IR was measured on FTIR
Shimadzu IRAffinity-1 with MIRacle, MS was measured on LCMS-2020 Shimadzu for ESI and
HRSIMS on Thermo Scientific Electron Transfer Dissociated (ETD) Orbitrap Fusion FSN
10314-1. The NMR data was recorded on Bruker Avance with Cryoprobe (500 MHz) and Bruker
Ascend (400 MHz) using deuterated chloroform (CDCl3) and d4-methanol as solvents with TMS
as an internal solvent. Melting points were measured on a Buchi M.560 apparatus and optical
rotation was measured on Jasco P-2000 polarimeter. The short-circuit current and chloride
current (Isc , ICl-) were measured on using a DVC-1000 voltage-clamp (World Precision
Instruments, Sarasota, FL, U.S.A.) with Ag/AgCl electrodes and 1 M KCl agar bridges.

4.2. Plant Material
The roots of N. mitis were collected from Kabwir in Kanke Local Government Area of
Plateau state, Nigeria in July 2016. The plant was identified by botanist Mr Otuwose Agyeno of
the Department of Plant Science and Technology, University of Jos, Nigeria. The plant sample
was deposited in the University of Jos herbarium where the voucher number was allocated as
UJ16000246.
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4.3. Extraction and Isolation
The roots of N. mitis were washed with water and shredded into small pieces and dried in an
oven at 45 °C for 2 d. The dried root was pulverized using a mortar and pestle. About 1000 g of
the powder was successively extracted for 72 h with dichloromethane (DCM, 4 L) and then
ethanol (4 L). The extracts were filtered through a sieve (150 µm), a cotton plug and then filter
paper. The filtrates were dried under a constant stream of air provided by a laboratory electric
fan overnight, to obtain dark brown solids for both extracts. The yields for the DCM and ethanol
extracts were 15 g (1.5%) and 10 g (1%), respectively. Both extracts show similar TLC profiles.
A portion of the DCM extract (14 g) was separated by column chromatography (CC) over silica
gel using a gradient system from ethyl acetate (EtOAc)/hexanes (1:9) to 100% EtOAc to yield 40
fractions; these were combined based on their similarities by TLC and NMR analysis to afford
12 fractions (F1-F12). Fraction F2 (150 mg) was separated by CC over silica gel using a gradient
system from EtOAc/hexanes (1:9) to 100% EtOAc to give seven sub-fractions (F2f1-F2f7). Subfraction F2f5 was triturated with hexane, the hexane was decanted to leave a white solid
identified as compound 1 (9.2 mg). Fraction F3 (490. mg) was purified by CC over silica gel
using a gradient system from EtOAc/hexanes (1:9) to 100% EtOAc to give compound 2 (343
mg) as a white solid. Separation of fraction F4 (150 mg) by CC over silica gel and elution with a
gradient system of hexanes/DCM (95:5) gave ten sub-fractions (F4f1-F4f10). Evaporation of
sub-fraction F4f5 gave compound 3 (22 mg) as a white solid. Fraction F5 (90 mg) yielded five
sub-fractions (F5f1-F5f5), when chromatographed on silica gel by elution with hexanes/ DCM
(5:95). Evaporation of sub-fraction F5f3 gave compound 4 (1.9 mg) as a white solid. Fraction F6
(250 mg) was separated by CC over silica gel by elution with hexanes/DCM (5:95) to give ten
sub-fractions (F6f1-F6f10), F6f3 was crystallized from DCM/hexanes (1:3) to give large white
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crystals identified as compound 5 (82 mg). Fraction F7 (560 mg) was separated by CC over
silica gel using a gradient system of EtOAc/DCM (2:98) to give seven sub-fractions (F7f1-F7f7).
Evaporation of sub-fraction F7f4 gave compound 6 (15 mg) as a yellow solid, while, evaporation
of sub-fraction F7f5 gave compound 7 (227 mg) as white needles. Fraction F8 (380.0 mg) was
separated by CC over silica gel elution with EtOAc/DCM (5:95) to give 15 sub-fractions (F8f1F8f15). The purification of sub-fraction F8f2 (19 mg) by prep. TLC with elution with
EtOAc/DCM (5:95) yielded compounds 8 (4.9 mg) as a white solid, and 9 (3.9 mg) as a yellow
solid. Sub-fractions F8f3, F8f5, and F8f8 respectively provided compounds 10, (84.1 mg) as
brown solid and compounds 11 (15.4 mg) and 12 (15.0 mg) as white sticky solids. Compound 11
was identified by X-ray crystallography; single white crystals were grown from DCM/hexanes
(1:3). Sub-fractions F8f9 and F8f10 were combined based on their TLC and NMR spectrum
similarities and named F8f910 (15 mg) which was purified by prep. TLC with elution with
EtOAc/DCM (95:5) to yield compounds 13 (4.5 mg) and 14 (2.7 mg), both as white sticky
solids. Fraction 9 (160 mg) was separated by CC over silica gel with a gradient system of
EtOAc/CH2Cl2 (5:95) to afford ten sub-fractions (F9f1-F9f10), on the bases of their TLC
similarities, sub-fractions F9f5, F9f6 and F9f7 were combined, evaporated and the solid residue
was triturated with hexane to obtain a white powder identified as compound 15 (9.1 mg).
Fraction F10 (1.18 g) was purified by CC over silica gel elution with DCM/CH2Cl2 (5:95) to
afford 26 sub-fractions (F10f1-F10f26). Sub-fractions F10f16 to F10f21 were combined based
on their TLC and NMR similarities. The combined fraction (215 mg) was triturated with
methanol and the soluble portion (113 mg) was separated by CC over Sephadex (LH20) by
elution with 100% methanol to yield four fractions (A-D). Fraction B was purified once more by
CC over Sephadex (LH20) by elution with 100% methanol to yield compound 16 (19.2 mg), as
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yellow needles and compound 17 (9.4 mg) as a brown solid. Fraction F11 (90 mg) was separated
by CC over silica gel using a gradient system of EtOAc/DCM (10:90) to yield ten fractions
(F11f1-F11f10). Sub-fraction F10f6 was identified as compound 18 (21.3 mg) with a white
fluffy appearance. Fraction F12 (2.28 g) was evaporated, washed with methanol to obtain the
methanol soluble portion (1.18 g), which was separated by CC over Sephadex (LH20) by elution
with 100% methanol to obtain ten sub-fractions (F12f1-F12f10). Sub-fractions F12f7, F12f8 and
F12f9 were combined based on their TLC and NMR similarities. The combined portion was
again purified over Sephadex (LH20) by elution with 100% methanol to yield two fractions (A
and B). Fraction A (2.9 mg) a white solid was identified as compound 19 (2.9 mg), while
fraction B was further washed with DCM to obtain a white solid (15 mg) which was crystallized
from methanol, DCM, hexanes (1:1:2) and the white crystal were identified as compound 20 (15
mg).

4.3.1. Preparation of aqueous extract and isolation of chloroform soluble compounds
The aqueous root extract (ABAQ) of N. mitis was prepared as described (Dawurung et al.,
2019), and about 1 g of ABAQ was dissolved in chloroform, filtered and evaporated in rotary
evaporator to obtain a yield of 291.1 mg, which is tagged ABAQ-Chlo. The whole amount of
ABAQ-Chlo was chromatographed on CC over silica gel using a gradient system from
EtOAc/hexanes (2:8) to 100% EtOAc to give eight fractions (F1-F7). Fraction F1 (11.7 mg) was
identified as compound 2, while fraction F4 was confirmed as compound 7 (11.1 mg).
Compound 6 (5.8 mg) was purified from fraction F5, and fraction F6 resulted in compound 18
(7.1 mg).
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4.4. Short-circuit current (ISC) and apical Cl- current (ICl-) measurement
T84 and Calu-3 cells were obtained from American Type Culture Collection (Manassas, VA,
USA). They were maintained in DMEM and Ham’s F-12 medium (1:1) supplemented with 10%
fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin, at 37 °C under a
humidified 95% O2/5% CO2 atmosphere. T84 and Calu-3 cells at the density of 5×105 cells/insert
were seeded in snapwellTM insert, and cultured in a humidified incubator with replacement of the
cultured medium on alternate day. After transepithelial electrical resistance of the cells
monolayer reached 1000 Ω•cm2 as measured by an EVOM2 volt-ohm meter (World Precision
Instruments, Sarasota, Florida, USA), the cells were mounted in an Ussing chamber. For ISC
analysis, both hemichambers were filled with Kreb’s solution (pH 7.4) containing 20 mM NaCl,
25 mM NaHCO3, 3.3 mM KH2PO4, 0.8 mM K2HPO4, 1.2 mM MgCl2, 1.2 mM CaCl2 and 10
mM glucose. For apical ICl- analysis, basolateral-to-apical Cl- gradient buffers were applied. The
basolateral high Cl- buffer (pH 7.4) was composed of 130 mM NaCl, 2.7 mM KCl, 1.5 mM
KH2PO4, 1 mM CaCl2,0.5 mM MgCl2, 10 mM Na-HEPES (pH 7.4) and 10 mM glucose. In
apical low Cl- buffer (pH 7.4), 65 mM NaCl was substituted with 65 mM sodium gluconate, and
the CaCl2 concentration was increased to 2 mM. In addition, amphotericin B (250 µg/mL) was
added into the basolateral solution 20 min before ICl- measurement to capacitate basolateral
membrane permeabilization. The solutions were maintained at 37 ºC with bubbling of 95%
O2/5% CO2 for the ISC measurements, or 100% O2 for the ICl- measurements (Phrutivorapongkul
et al., 2002; Satitsri et al., 2016).

4.5. Mouse model of cholera toxin-induced intestinal fluid secretion
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ICR male mice (30-35g) were obtained from Nomura Siam International, Pathumwan,
Bangkok, Thailand. Mice were maintained under a controlled environment (temperature 25 ± 1
°C; humidity 30–70%; 12:12 h dark-light). Mice were fasting for 24 h prior to the experiment.
After that, mice were anesthetized by intraperitoneal administration of thiopental (50 mg/kg).
During the surgery, the body temperatures of the mice were maintained at 37 °C using heating
pads. Abdominal incision was made and the ileal segment of the small intestine was ligated twopoint in 2-3 cm length with sterile silk thread. Ileal loops were instilled with 100 µL of
phosphate-buffered saline (PBS) or PBS containing cholera toxin (1 µg/loop) with or without
intraluminal administration of compound 10 (16.9 µg/loop). The abdomen was closed and mice
were allowed to recover from anaesthesia. After 6 h, both mice were euthanized for collection of
lileal loops. The weight/length ratios of ileal loops were measured and were used as an indicator
of intestinal fluid secretion. This study has been approved by the Institutional Animal Care and
Use Committee of the Faculty of Science, Mahidol University (Muanprasat and Chatsudthipong,
2013).

4.6. Cytotoxicity
Three mammalian cells: KB cells, (mouth epidermal carcinoma cells), Vero cells (kidney
African green monkey epithelial cells) and BHK cells (baby hamster kidney fibroblasts) were
cultured at 37 °C in a 5% CO2 incubator. KB and BHK cells were maintained in DMEM
Dulbecco's Modified Eagle media supplemented with 10% fetal bovine serum (FBS), 3.7 g/L
sodium bicarbonate and 1% MEM non-essential amino acids. For BHK21 cell, the media was
also supplemented with 1% glutamax. Vero cell was maintained in in Minimal Essential Medium
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with Earle’s salts (MEM/EBSS) supplemented with 10% FBS, 2.2 g/L sodium bicarbonate and 1
mM sodium pyruvate.
For in vitro cytotoxicity assays, the crude extract/ pure compound stocks were dissolved DMSO
and then diluted with cell culture medium. 25 µL of working crude extracts/ pure compounds
were added to each well of a 96 wells-plate containing 125 µL growth media. Then, the cells
were plated at a density of 19, 000 cells/well. Following 72 h incubation, 100 µL of 10%
trichloroacetic acid was added to each well and the plates incubated at 4 °C for 45 min. Fixed
cells were washed with distilled water, air-dried and stained with 0.057% (w/v) sulforhodamine
B in 1% acetic acid. The plate was incubated in the dark for 30 minutes. The wells were washed
four times with 1% acetic acids and air dried. Then, 200 µL of 10X Tris-buffer was added to
each well and shaken for 30 min at 400 rpm. The absorbance for each well was measured at 510
nm wavelength in a microplate reader. The 50% inhibitory concentration (IC50) values of the
crude extracts/ pure compounds were determined following literature procedures (Cullen et al.,
2016; Vichai et al., 2006; Wangchuk et al., 2011).

4.7. Statistical analysis
Results were presented as means ± S.E.M. Student’s t test or One-way ANOVA with Tukey’s
post test was performed to evaluate statistical difference between control and treatment groups,
where appropriate. p value < 0.05 was considered as statistical significance.

4.8. Crystal structure data
The crystal data of 11 and 20 have been deposited with the Cambridge Crystallographic Data
Centre and assigned a supplementary publication numbers, CCDC 1973442 for 11 and CCDC
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1972703 for 20. These data can be access from Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/data_request/cif.
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